News Daily News Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year Caitlin E. Cox May 08, 2020
News Daily News Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes Todd Neale April 11, 2019
News Daily News Atherosclerosis Features Differ Among Male Athletes From Different Sports Todd Neale February 18, 2019
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015